Author

Liang Ye

Shenzhen UniversityORCID 0000-0002-6735-0836Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liang Ye1 paper · Corteva (United States)

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adam KawałekiD· 1 shared Anmin Ren· 1 shared Jan‐Willem VeeningiD· 1 shared Jinzhao OuiD· 1 shared Liang YangiD· 1 shared Ning JiaiD· 1 shared Tingting ZhangiD· 1 shared Vincent de BakkeriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adam KawałekORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa

Yu Zhang, Tingting Zhang, Xue Xiao, Yejun Wang, Adam Kawałek, Jinzhao Ou, Anmin Ren, Wenhao H. Sun, Vincent de Bakker, Yujie Liu, Yuelong Li, Liang Yang, Liang Ye, Ning Jia, Jan‐Willem Veening, Xue Liu

The paper uses CRISPRi-seq to identify FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa, enhancing gallium's efficacy against infections.

Nature Communications · Jul 1, 2025Peer-reviewedMicrobiology